Back to Search
Start Over
ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC
- Source :
- Journal of Thoracic Oncology. 11:S250-S251
- Publication Year :
- 2016
- Publisher :
- Elsevier BV, 2016.
- Subjects :
- 0301 basic medicine
Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
First line
Checkmate
Ipilimumab
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Medicine
Medical physics
Nivolumab
business
medicine.drug
Subjects
Details
- ISSN :
- 15560864
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- Journal of Thoracic Oncology
- Accession number :
- edsair.doi...........7d5507332d6c10470ffb8ce8668d3189